Cirrhosis and multiple organ damage

Authors

  • Chiriboga-Ortiz Ana Universidad Laica Eloy Alfaro de Manabí. Manta, Ecuador.

Keywords:

Liver cirrhosis, Multiple organ damage, health

Abstract

Chronic and progressive cirrhosis of the liver, which can have many different causes, is distinguished by excessive fibrosis of liver tissue and changes in lobular architecture. Chronic inflammation, oxidative stress, and mitochondrial dysfunction are linked in a negative feedback loop that develops as cirrhosis worsens, eventually resulting in cell damage and hepatocellular death. The term "multi-organ dysfunction syndrome in cirrhosis" (MODS) was created as evidence for the involvement of organs other than the liver in cirrhotic patients. Due to the dysfunctional release of inflammatory, endothelial, and coagulation mediators by the liver, bacterial translocation, and the immune response, this syndrome involves a number of changes in systems, including the renal, cardiovascular, pulmonary, and brain systems, among others. others. The morbidity and mortality of patients with cirrhosis are significantly affected by multi-organ dysfunction, which also affects quality of life, complicates liver transplant evaluation, increases the risk of surgery, and increases surgical risk. The clinical management and quality of life of people with cirrhosis will improve with a deeper understanding of the interactions between the various organs and systems.

Keywords: Liver cirrhosis, Multiple organ damage, health.

Downloads

Download data is not yet available.

References

Boboš, Marina & Nenadic, Irina & Djuric, Marko & Vukotic, Aleksandra & Culjic, Radmila & Stevanovic, Predrag. (2022). Preoperativna priprema pacijenata sa cirozom Preoperative evaluation of patients with cirrhosis. Materia Medica. 35. 1802-1817.

Buey, L. G., Mateos, F. G., & Moreno-Otero, R. (2012). Cirrosis hepática. Medicine-Programa de formación médica continuada acreditado, 11(11), 625-633.

Fortea, J. I., Carrera, I. G., Puente, A., & Crespo, J. (2020). Cirrosis hepática. Medicine-Programa de Formación Médica Continuada Acreditado, 13(6), 297-307.

García, D. R., & Cañizares, R. B. (2016). Cirrosis hepática. Medicine: Programa de Formación Médica Continuada Acreditado, 12(11), 597-605.

Medina Lois, E., & Kaempffer Ramírez, A. M. (2002). Cirrosis hepática en Chile. Rev. chil. salud pública, 7-14.

Rakhman, Mahendra & Indriani, Vitasari & E, Dwi. (2021). CORRELATION OF ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX (APRI) WITH THE DEGREE OF SEVERITY LIVER ORGAN IN CIRRHOSIS HEPATIC PATIENTS. Mandala Of Health. 14. 16. 10.20884/1.mandala.2021.14.1.3074.

Rincón, D., & Bañares, R. (2016). Cirrosis hepática. Medicine-Programa de Formación Médica Continuada Acreditado, 12(11), 597-605.

Sakharkar, Sheetal & Gujar, Samrudhi & Tembhare, Vaishali & Wagh, Pranali & Khandar, Jaya & Shambharkar, Madhuri & Kolhekar, Sonali & Pande, Khushbu. (2021). Case Report on Cirrhosis of Liver. Journal of Pharmaceutical Research International. 171-175. 10.9734/jpri/2021/v33i52A33572.

Shchyokotova, A. (2022). Liver cirrhosis. Perm Medical Journal. 39. 41-57. 10.17816/pmj39441-57.

Tkachenko, T. & Shevchuk, S. & Masik, N. (2022). Acute decompensation of liver cirrhosis and acute-on-chronic liver failure: diagnostic and prognostic criteria, treatment strategy. Reports of Vinnytsia National Medical University. 26. 644-652. 10.31393/reports-vnmedical-2022-26(4)-22.

Published

2022-01-20

How to Cite

Chiriboga-Ortiz, A. (2022). Cirrhosis and multiple organ damage. BIOSANA Health Scientific Journal. ISSN 2960-8481, 2(3), 6–10. Retrieved from https://soeici.org/index.php/biosana/article/view/42